Хайлтын үр дүнгүүд - Daniel Eriksson
- 35-н 1 - 20 үр дүнгүүдийг харуулж байна
- Дараагийн хуудас руу очих
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
Loncastuximab Tesirine Versus Polatuzumab Vedotin Plus Bendamustine and Rituximab in Relapsed/Refractory DLBCL After ≥ 2 Lines of Therapy: Matching-Adjusted Indirect Comparison -н Koo Wilson, Francesca Chiodi, Abby Paine, Zalmaï Hakimi, Victoria Ward, Thomas Macmillan, Daniel Eriksson, Silvia Mappa
Хэвлэсэн 2025Revisão -
18
-
19
-
20
Rivaroxaban’s Impact on Renal Decline in Patients With Nonvalvular Atrial Fibrillation: A US MarketScan Claims Database Analysis -н Craig I Coleman, Reinhold Kreutz, Nitesh Sood, Thomas J. Bunz, Anna‐Katharina Meinecke, Daniel Eriksson, William L. Baker
Хэвлэсэн 2019Artigo
Хайх хэрэгслүүд:
Холбогдох сэдвүүд
Medicine
Internal medicine
Biology
Disease
Immunology
Gene
Antibody
Genetics
Autoantibody
Computational biology
Immune system
Diabetes mellitus
Endocrinology
Inflammation
Adipocyte
Adipose tissue
Arthritis
Artificial intelligence
Autoimmune disease
Autoimmunity
Bioinformatics
Cancer research
Computer science
Insulin
Insulin resistance
Machine learning
Pathology
Type 2 diabetes
Artery
Asymptomatic